Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
NCT05658874 · View on ClinicalTrials.gov ↗
Study Summary
The goal of this clinical trial is to compare two different treatment patterns in patients with chronic bladder pain. The main questions the investigators are seeking to answer is if bladder pain improves before and after treatment using a painful bladder scale. The participant will have 5 visits to evaluate your symptoms with questionnaires, at least one procedural visit, and must participate in physical therapy and some kind of behavioral health therapy. This study will assess participant response to a bundled-care approach to chronic bladder pain both pre-and post intervention as well as compared to a group of participants receiving typical care.
Conditions Studied
Interventions
- DRUG Multimodal Bundle Drugs
- PROCEDURE Operative Cystoscopy
- BEHAVIORAL Behavioral health consultation/therapy
- OTHER Pelvic floor physical therapy
- OTHER Usual Urogynecologic care
Study Locations (1)
Pennsylvania
- Magee Womens Hospital — Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 3 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05658874
The ClinicalTrials.gov registry entry for NCT05658874 describes a study currently listed as active not recruiting. It is categorized as Phase 3, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jocelyn Fitzgerald, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 5 interventions — of which Multimodal Bundle Drugs is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05658874 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05658874 about?
NCT05658874 is a clinical study titled "A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain". The goal of this clinical trial is to compare two different treatment patterns in patients with chronic bladder pain. The main questions the investigators are seeking to answer is if bladder pain improves before and after treatment using a painful bladder scale. The participant will have 5 visits to...
What is the current status of trial NCT05658874?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 26 participants. The study started on 2022-12-01. Estimated completion is 2025-10-31.
What conditions does trial NCT05658874 study?
This clinical trial studies the following conditions: Interstitial Cystitis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05658874?
The interventions under investigation include: Multimodal Bundle Drugs (DRUG), Operative Cystoscopy (PROCEDURE), Behavioral health consultation/therapy (BEHAVIORAL), Pelvic floor physical therapy (OTHER), Usual Urogynecologic care (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05658874?
This trial is sponsored by Jocelyn Fitzgerald, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05658874 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.